EcoDrugPlus

Ribosomal Protein L3

Ensembl ID : ENSCAFG00020002524
Gene Symbol: RPL3
2 Cross references
284 Possible Orthologues:

Ribosomal Protein L32

Ensembl ID : ENSCAFG00020007109
Gene Symbol: RPL32
1 Cross references
80 Possible Orthologues:

Ribosomal Protein L35a

Ensembl ID : ENSCAFG00020003355
Gene Symbol: RPL35A
3 Cross references
197 Possible Orthologues:

Ribosomal Protein L36a

Ensembl ID : ENSCAFG00020007383
Gene Symbol: RPL36A
3 Cross references
85 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSCAFG00020008355
Gene Symbol: RPL4
2 Cross references
280 Possible Orthologues:

Ribosomal Protein L7

Ensembl ID : ENSCAFG00020017800
Gene Symbol: RPL7
2 Cross references
374 Possible Orthologues:

Ribosomal Protein L7a

Ensembl ID : ENSCAFG00020001122
Gene Symbol: RPL7A
2 Cross references
163 Possible Orthologues:

Ribosomal Protein L8

Ensembl ID : ENSCAFG00020021034
Gene Symbol: RPL8
3 Cross references
272 Possible Orthologues:

Ribosomal Protein L9

Ensembl ID : ENSCAFG00020002170
Gene Symbol: RPL9
3 Cross references
202 Possible Orthologues:

Ribosomal Protein S10

Ensembl ID : ENSCAFG00020006238
Gene Symbol: RPS10
3 Cross references
203 Possible Orthologues:

Ribosomal Protein S11

Ensembl ID : ENSCAFG00020024909
Gene Symbol: RPS11
3 Cross references
181 Possible Orthologues:

Ribosomal Protein S12

Ensembl ID : ENSCAFG00020021808
Gene Symbol: RPS12
3 Cross references
157 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).